BTK inhibitors vs BCL2 inhibitors in untreated CLL_Susan O'Brien, MD; #DDHO2021
2:30
Chronic Lymphocytic Leukemia
BTK inhibitors vs BCL2 inhibitors in untreated CLL_Susan O'Brien, MD; #DDHO2021
Chronic Lymphocytic Leukemia Similar Videos
Similar Videos
-
Module 4: Emerging BTK Inhibitors_Matthew Davids, MD, MMSc_Catherine Coombs, MD_Anthony Mato, MD, MSCE
12:02
-
Module 2: Acalabrutinib for Hematologic Malignancies_Matthew Davids, MD, MMSc_Catherine Coombs, MD_Anthony Mato, MSCE
8:16
-
Module 5: Experts Debate Optimal Selection and Sequencing Strategies_Matthew Davids, MD, MMSc_Catherine Coombs, MD_Anthony Mato, MD, MSCE
21:45
